Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

ProPhase Labs, Inc. (PRPH) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

ProPhase Labs, Inc. (PRPH), most recent 12 months reported: revenue $3.85M, net loss $22.46M, free cash flow -$8.34M. Latest balance sheet on file: liquid cash $20K. From SEC filings. Others in Pharmaceutical Preparations: KYNTRA BIO, INC. · Ensysce Biosciences, Inc. · CAMP4 Therapeutics Corporation · CHINA PHARMA HOLDINGS, INC. · MARKER THERAPEUTICS, INC. · NRX Pharmaceuticals, Inc. · TherapeuticsMD, Inc. · XENETIC BIOSCIENCES, INC.

Stock screener

Watchlist